EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Plant-Derived Compounds as Potential Sensitizers to Immunotherapy in Melanoma

Oana Bătrîna iD, Roxana Negrea-Ghiulai, Liana Suciu, Roxana Racoviceanu iD, Elisabeta Atyim iD, Mihaela Jorgovan iD, Tamara Maksimovic, Alexandra Mioc iD, Cristina Trandafirescu, Codruța Șoica, Marius Mioc

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27104423 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Oana Bătrîna und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, "Victor Babeș" University of Medicine and Pharmacy, 2 Eftimie Murgu Square, 300041 Timisoara, Romania. Hauptthemen laut MEDLINE: Melanoma, Immunotherapy, Phytochemicals, Skin Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 286 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii, Romanian National Authority for Scientific Research, “Victor Babes” University of Medicine and Pharmacy Timisoara.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Compounds of plant origin have increasingly emerged as anticancer agents through direct cytotoxicity and sensitizing mechanisms. Melanoma remains the most aggressive form of skin cancer that exhibits a steadily increasing number of new cases globally each year, thus urgently requiring more effective therapeutic strategies. Therefore, phytochemicals can be considered promising candidates, particularly when used in combination with immune checkpoint inhibitors. Their ability to optimize therapeutic efficacy and strengthen antitumor immune responses is mediated through various mechanisms that include the stimulation of T cell activity, the regulation of the TME, the activation of intrinsic immune responses and cytokine signaling, and the regulation of immune checkpoints such as PD-1/PD-L1, CTLA-4, and LAG-3. Additionally, these compounds can alter key signaling pathways that control immune regulation. Nevertheless, the extrapolation of preclinical studies to clinical applications remains limited by insufficient clinical evidence, the lack of standardized therapeutic protocols, and poor pharmacokinetic behavior. Consequently, further studies are required in order to clarify their actual efficacy and to better define their role in modern oncology. This article aims to review the mechanisms that underlie the anticancer sensitizing activity of major classes of plant-derived compounds such as polyphenols, flavonoids, terpenoids, alkaloids, and isothiocyanates. The available preclinical and clinical evidence were reported together with their potential synergistic effects when combined with immune checkpoint inhibitors. An important aspect related to the anticancer effects of these compounds lies in their ability to simultaneously target multiple signaling pathways. Furthermore, advanced formulations such as nanoparticulated delivery systems are discussed as strategies to optimize their clinical application and therapeutic outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaImmunotherapyPhytochemicalsSkin NeoplasmsHumansAnimalsImmune Checkpoint InhibitorsSignal Transduction

Stichwörter der Autor:innen

checkpoint modulationimmune activationmelanomaplant-derived compoundstumor microenvironment

Substanzen

PhytochemicalsImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Faculty of Pharmacy, "Victor Babeș" University of Medicine and Pharmacy, 2 Eftimie Murgu Square, 300041 Timisoara, Romania.
  • Research Centre for Experimental Pharmacology and Drug Design (X-Pharm Design), "Victor Babes" University of Medicine and Pharmacy, 2 Eftimie Murgu Square, 300041 Timisoara, Romania.

ORCID-Profile: Oana Bătrîna, Roxana Racoviceanu, Elisabeta Atyim, Mihaela Jorgovan, Alexandra Mioc

Förderung

  • Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii
  • Romanian National Authority for Scientific Research
  • “Victor Babes” University of Medicine and Pharmacy Timisoara

Zitieren

APA

Bătrîna, O., Negrea-Ghiulai, R., Suciu, L., Racoviceanu, R., Atyim, E., Jorgovan, M., Maksimovic, T., Mioc, A., Trandafirescu, C., Șoica, C., & Mioc, M. (2026). Plant-Derived Compounds as Potential Sensitizers to Immunotherapy in Melanoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27104423

Vancouver

Bătrîna O, Negrea-Ghiulai R, Suciu L, Racoviceanu R, Atyim E, Jorgovan M, et al. Plant-Derived Compounds as Potential Sensitizers to Immunotherapy in Melanoma. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27104423

BibTeX
@article{Btrna2026,
  author = {Bătrîna, Oana and Negrea-Ghiulai, Roxana and Suciu, Liana and Racoviceanu, Roxana and Atyim, Elisabeta and Jorgovan, Mihaela and Maksimovic, Tamara and Mioc, Alexandra and Trandafirescu, Cristina and Șoica, Codruța and Mioc, Marius},
  title = {Plant-Derived Compounds as Potential Sensitizers to Immunotherapy in Melanoma},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27104423}
}
Kostenlos starten →